Articles |
 Page 1 of 2  |
Nitric oxide synthase a contributor to hepatitis pathology.
December 30, 2002
|
New test quickly identifies both surface and e antigen of hepatitis B.
December 30, 2002
|
Risk for hepatitis C virus in semen presents need for laboratory cauti...
December 30, 2002
|
Interferon enhances long-term lamivudine use for hepatitis B virus.
December 30, 2002
|
Lamivudine prophylaxis disables chemotherapy-related viral reactivatio...
December 30, 2002
|
Histologic activity of childhood chronic hepatitis B studied.
December 30, 2002
|
Rodents could be reservoir for hepatitis E virus transmissions.
December 30, 2002
|
ViroLogic signs preferred provider agreement and equity agreement.
December 30, 2002
|
HCV core protein interferes with protein transport to nucleus.
December 30, 2002
|
HCV in the stomach associated with inflammatory response to H. pylori.
December 30, 2002
|
Study finds higher HCV seropositivity in patients with age-related cat...
December 30, 2002
|
Bleach-disinfected syringes may help protect injecting drug users agai...
December 30, 2002
|
Long-term follow-up conducted of chronic hepatitis C in Japan.
December 30, 2002
|
Distribution of HCV genotype and HGV coinfection rate in Saudi Arabia ...
December 30, 2002
|
Genetic analysis conducted of HCV transmission among injection drug us...
December 30, 2002
|
WHO reports on model of hepatitis C virus infection in the U.S.
December 30, 2002
|
Drug discovery labs expanded.
December 30, 2002
|
Viral-disease focused biotech releases third quarter 2002 financial re...
December 30, 2002
|
Viral-disease focused biotech announces $7.0 million private placement...
December 30, 2002
|
Murine model of acute hepatitis B virus infection developed.
December 30, 2002
|
New data shows ISIS 14803 produces significant viral level reductions.
December 30, 2002
|
Short-term induction treatment with IFN doesn't improve long-term outc...
December 30, 2002
|
IFN therapy doesn't prevent liver cancer in HCV-compensated cirrhosis.
December 30, 2002
|
High-intensity regimen for chronic HCV genotype lb infection not well ...
December 30, 2002
|
Human serum albumin-interferon-alpha fusion protein studied.
December 30, 2002
|
SEC charges settled.
December 30, 2002
|
Cardiovascular disease risk factors decline after liver implantation.
December 30, 2002
|
Role of hepatitis B virus X protein in infection elucidated.
December 30, 2002
|
Immune deficiency in Nijmegen breakage syndrome is variable, progressi...
December 30, 2002
|
Patient violence greatest threat to ED workers; EDs unready for bioter...
December 30, 2002
|
Reverse seroconversion of HBV not uncommon among HBsAG+ recipients.
December 30, 2002
|
Researchers use phylogenetics to study virus' evolution.
December 30, 2002
|
Erosive vulvar lichen planus may contribute to intrapartner spread of ...
December 30, 2002
|
Lamivudine adds layer of protection to recipients of core-positive liv...
December 23, 2002
|
Infants of hepatitis B virus carriers benefit from vaccine alone.
December 23, 2002
|
Chromogranin A could be marker for primary liver cancers.
December 23, 2002
|
Interleukin-18 inhibits viral replication in livers of transgenic mice...
December 23, 2002
|
Pediatric travelers benefit from accelerated vaccine schedule.
December 23, 2002
|
Steroids plus infliximab significantly lower Maddrey's scores.
December 23, 2002
|
Study finds psychiatric comorbidities common among veterans with chron...
December 23, 2002
|
PCR may be useful to assess inactivation of hepatitis A virus by chlor...
December 23, 2002
|
FDA committee recommends approval of Pegasys with Copegus.
December 23, 2002
|
Interferon treatment causes major depression in many patients.
December 23, 2002
|
Rel/NF-kappa B transcription factors regulate apoptosis of HCC cells.
December 23, 2002
|
Fusion protein improves dosing profile of standard interferon.
December 23, 2002
|
TaqMan real-time PCR assay is sensitive, reliable for quantitating HCV...
December 23, 2002
|
Embolization feasible for treating certain hepatocellular carcinoma pa...
December 23, 2002
|
First healthcare center targeted to injection drug users opens in New ...
December 23, 2002
|
Low investment in immunization and vaccines threatens global health.
December 23, 2002
|
Fractionated particles reveal complexity of hepatitis C virus infectio...
December 16, 2002
|
Synthetic ribozymes a potential treatment for hepatitis B virus.
December 16, 2002
|
Hepatitis C-positive kidneys increase mortality risk.
December 16, 2002
|
Several factors confound survival odds in liver cancer transplant reci...
December 16, 2002
|
Susan Scher, MD, named VP of small-molecule drug manufacturer.
December 16, 2002
|
Investigational new drug application submitted for Hepavir B.
December 16, 2002
|
New noninvasive liver fibrosis test launched.
December 16, 2002
|
Study evaluates performance of INNO-LiPA HBV DR assay.
December 16, 2002
|
Nanofiltration removes viruses from human immunoglobulin manufacturing...
December 16, 2002
|
Laboratory Corp. of America announces third quarter results.
December 16, 2002
|
Recombinant antibody Fab blocks HCV adsorption to susceptible cells in...
December 16, 2002
|
Beta-L-Fd4C inhibits both wild-type, lamivudine-resistant HBV.
December 16, 2002
|
Lamivudine doesn't increase interferon efficacy in mutant type hepatit...
December 16, 2002
|
Once-a-week dose of PegIntron may not be enough.
December 16, 2002
|
Viramidine to advance to phase II clinical trials.
December 16, 2002
|
Murine leptin deficiency alters Kupffer cell production of regulatory ...
December 16, 2002
|
FDA Approves Versant HCV RNA qualitative assay.
December 16, 2002
|
Lamivudine too little, too late for chronic hepatitis B flare.
December 16, 2002
|
Enzyme not indicative of sustained response after interferon.
December 09, 2002
|
Postsurgical hepatitis linked to shortened survival.
December 09, 2002
|
Gene rearrangements frequent in hepatitis C patients.
December 09, 2002
|
Gene transfer sensitizes liver cancer cells to chemotherapy.
December 09, 2002
|
Virus thrives in sweat glands of chronic hepatitis C patients.
December 09, 2002
|
Copper chelator trientine mediates liver cancer killing.
December 09, 2002
|
Time an enemy to liver cancer patients awaiting organ donation.
December 09, 2002
|
Profiles for sulphasalazine and mesalazine don't differ.
December 09, 2002
|
| More
articles from Hepatitis Weekly... |
